|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
WO2014117121A1
(en)
|
2013-01-28 |
2014-07-31 |
St. Jude Children's Research Hospital, Inc. |
A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease
|
|
CA2935960C
(en)
|
2014-01-08 |
2023-01-10 |
Bart Lipkens |
Acoustophoresis device with dual acoustophoretic chamber
|
|
KR102211120B1
(ko)
|
2014-05-15 |
2021-02-03 |
내셔널 유니버시티 오브 싱가포르 |
변형된 천연 살해 세포 및 그의 용도
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
EP3184548A1
(en)
*
|
2015-12-23 |
2017-06-28 |
Miltenyi Biotec GmbH |
Chimeric antigen receptor with cytokine receptor activating or blocking domain
|
|
EP3443096B1
(en)
*
|
2016-04-15 |
2023-03-01 |
Novartis AG |
Compositions and methods for selective expression of chimeric antigen receptors
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
IL269203B2
(en)
*
|
2017-03-13 |
2024-09-01 |
Poseida Therapeutics Inc |
Compositions and methods for selective elimination and replacement of hematopoietic stem cells
|
|
IL269553B2
(en)
|
2017-03-27 |
2025-10-01 |
Nat Univ Singapore |
Truncated NKG2D chimeric receptors and their uses in immunotherapy with natural killer cells
|
|
WO2018182511A1
(en)
|
2017-03-27 |
2018-10-04 |
National University Of Singapore |
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
|
|
BR102018006205A2
(pt)
*
|
2017-03-28 |
2021-03-23 |
Cell Design Labs, Inc. |
Polipeptídeos quiméricos e métodos de alterar a localização da membrana dos mesmos
|
|
US20230192839A1
(en)
*
|
2017-04-12 |
2023-06-22 |
Pfizer Inc. |
Antibodies having conditional affinity and methods of use thereof
|
|
US11939379B2
(en)
*
|
2017-05-19 |
2024-03-26 |
The Regents Of The University Of California |
Antibody chemically induced dimerizer (AbCID) as molecular switches for regulating cellular therapies
|
|
US20230159611A1
(en)
*
|
2017-07-03 |
2023-05-25 |
Yale University |
Small molecule adapter regulated, target specific chimeric antigen receptor bearing t cells (smart cars)
|
|
CN107312797B
(zh)
*
|
2017-07-28 |
2021-06-18 |
广州中科蓝华生物科技有限公司 |
一种蛋白调控系统及其制备方法和应用
|
|
CN111148533A
(zh)
|
2017-09-19 |
2020-05-12 |
麻省理工学院 |
用于嵌合抗原受体t细胞疗法的组合物及其用途
|
|
KR20200086278A
(ko)
|
2017-10-18 |
2020-07-16 |
노파르티스 아게 |
선택적 단백질 분해를 위한 조성물 및 방법
|
|
CN111565737A
(zh)
|
2017-12-14 |
2020-08-21 |
蓝鸟生物公司 |
Daric白细胞介素受体
|
|
SG11202005307RA
(en)
*
|
2017-12-14 |
2020-07-29 |
Bluebird Bio Inc |
Nkg2d daric receptors
|
|
SG11202003907WA
(en)
|
2017-12-14 |
2020-05-28 |
Flodesign Sonics Inc |
Acoustic transducer drive and controller
|
|
EP3502130A1
(en)
|
2017-12-20 |
2019-06-26 |
St. Anna Kinderkrebsforschung |
Ligand regulated protein-protein interaction system
|
|
WO2019122188A1
(en)
|
2017-12-20 |
2019-06-27 |
St. Anna Kinderkrebsforschung |
Ligand regulated protein-protein interaction system
|
|
CN111801348A
(zh)
|
2018-02-09 |
2020-10-20 |
新加坡国立大学 |
活化性嵌合受体及其在自然杀伤细胞免疫疗法中的用途
|
|
TW201934575A
(zh)
|
2018-02-11 |
2019-09-01 |
大陸商江蘇恆瑞醫藥股份有限公司 |
一種分離的嵌合抗原受體以及包含其的修飾ｔ細胞及用途
|
|
SG11202008976YA
(en)
|
2018-04-02 |
2020-10-29 |
Nat Univ Singapore |
Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
|
|
MX2020011254A
(es)
*
|
2018-04-27 |
2020-11-12 |
Crispr Therapeutics Ag |
Celulas t car anti-bcma para agotamiento de celulas de plasma.
|
|
GB201813178D0
(en)
*
|
2018-08-13 |
2018-09-26 |
Autolus Ltd |
Cell
|
|
EP3844186A4
(en)
|
2018-08-29 |
2022-08-17 |
National University of Singapore |
METHOD OF SPECIFIC STIMULATION OF SURVIVAL AND EXPANSION OF GENETICALLY MODIFIED IMMUNE CELLS
|
|
AU2019346335B2
(en)
|
2018-09-28 |
2024-07-25 |
Massachusetts Institute Of Technology |
Collagen-localized immunomodulatory molecules and methods thereof
|
|
EP4588483A3
(en)
*
|
2018-10-03 |
2025-09-24 |
University of Pittsburgh- Of the Commonwealth System of Higher Education |
Covalent adaptor synnotch and chimeric antigen receptors (cars) for programmable antigen-targeting
|
|
JP2022512594A
(ja)
*
|
2018-10-05 |
2022-02-07 |
ザンクト アンナ キンダークレプスフォルシュング |
キメラ抗原受容体（ｃａｒ）の群
|
|
EP3632461A1
(en)
|
2018-10-05 |
2020-04-08 |
St. Anna Kinderkrebsforschung |
A group of chimeric antigen receptors (cars)
|
|
CA3120563A1
(en)
|
2018-11-26 |
2020-06-04 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
EP3895052A4
(en)
|
2018-12-14 |
2022-10-26 |
2seventy bio, Inc. |
DIMERIZING AGENT REGULATED IMMUNORECEPTOR COMPLEXES
|
|
JP2022516919A
(ja)
*
|
2019-01-04 |
2022-03-03 |
ザ・ユニバーシティ・オブ・シカゴ |
Ｒｎａをモジュレートするためのシステムおよび方法
|
|
WO2020180882A1
(en)
|
2019-03-05 |
2020-09-10 |
Nkarta, Inc. |
Cd19-directed chimeric antigen receptors and uses thereof in immunotherapy
|
|
WO2020227071A1
(en)
|
2019-05-04 |
2020-11-12 |
Inhibrx, Inc. |
Cd123-binding polypeptides and uses thereof
|
|
CA3138972A1
(en)
|
2019-05-04 |
2020-11-12 |
Inhibrx, Inc. |
Clec12a-binding polypeptides and uses thereof
|
|
MX2021013416A
(es)
|
2019-05-04 |
2021-12-10 |
Inhibrx Inc |
Polipeptidos de union al antigeno cd33 y sus usos.
|
|
BR112021022356A2
(pt)
*
|
2019-05-08 |
2022-01-18 |
2Seventy Bio Inc |
Imunoterapias direcionadas a cd33
|
|
SG11202111927QA
(en)
*
|
2019-05-08 |
2021-11-29 |
2Seventy Bio Inc |
Cll-1 targeted immunotherapies
|
|
WO2020227481A1
(en)
*
|
2019-05-08 |
2020-11-12 |
Bluebird Bio, Inc. |
Cd123 targeted immunotherapies
|
|
US11642409B2
(en)
|
2019-06-26 |
2023-05-09 |
Massachusetts Insttute of Technology |
Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
|
|
WO2021061648A1
(en)
|
2019-09-23 |
2021-04-01 |
Massachusetts Institute Of Technology |
Methods and compositions for stimulation of endogenous t cell responses
|
|
JP2022551820A
(ja)
*
|
2019-10-15 |
2022-12-14 |
エフ．ホフマン－ラ ロシュ アーゲー |
細胞内または小胞内生体分子相互作用を検出するための人工膜貫通タンパク質
|
|
US20240156864A1
(en)
*
|
2019-10-31 |
2024-05-16 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for chimeric antigen receptor targeting cancer cells
|
|
AU2020401755A1
(en)
*
|
2019-12-11 |
2022-08-04 |
Cilag Gmbh International |
Multispecific binding molecules comprising LTBR and EDB binding domains and uses thereof
|
|
WO2021221782A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Chimeric antigen receptor-targeting ligands and uses thereof
|
|
WO2021221783A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
|
|
IL299276A
(en)
*
|
2020-06-22 |
2023-02-01 |
Univ Ramot |
Multi subunit protein modules, cells expressing same and uses thereof
|
|
CA3172530A1
(en)
|
2021-02-25 |
2022-09-01 |
Spencer PARK |
Ror1 targeting chimeric antigen receptor
|
|
US20260083848A1
(en)
|
2021-11-03 |
2026-03-26 |
Viracta Therapeutics, Inc. |
Combination of car t-cell therapy with btk inhibitors and methods of use thereof
|
|
CN120435306A
(zh)
*
|
2022-09-20 |
2025-08-05 |
丹娜-法伯癌症研究院 |
嵌合抗原受体t细胞的可逆控制
|
|
CN119638840A
(zh)
*
|
2023-09-15 |
2025-03-18 |
东莞市朋志生物科技有限公司 |
一种抗糖类抗原153的抗体及其应用
|